Shareholder Alert: Ademi LLP Investigates Whether Sharecare, Inc. Has Obtained a Fair Price for Its Public Shareholders
Shareholder Alert: Ademi LLP Investigates Whether Sharecare, Inc. Has Obtained a Fair Price for Its Public Shareholders
MILWAUKEE, June 21, 2024 /PRNewswire/ -- Ademi LLP is investigating Sharecare (Nasdaq: SHCR) for possible breaches of fiduciary duty and other violations of law in its transaction with Altaris.
Ademi LLP正在調查Sharecare（納斯達克：SHCR）的可能違反信託責任和其他法律違規行爲。.
Click here to learn how to join the or call Guri Ademi toll-free at 866-264-3995. There is no cost or obligation to you.
點擊這裏了解如何加入或者免費撥打Guri Ademi的電話號碼866-264-3995。您沒有任何費用或者義務。
In the transaction, Sharecare public shareholders will receive $1.43 per share for each outstanding share of Sharecare common stock held. Jeff Arnold has agreed to vote his shares in favor of the transaction, and will roll over substantially all of his existing equity and continue to be a significant shareholder following this transaction. In addition, Arnold will continue to serve as executive chairman and Layton as CEO, and Sharecare's current executive leadership team is expected to continue in their roles following the close of the transaction. Together, all directors and executive officers as a group own approximately 30% of the outstanding shares.
在該交易中，Sharecare的公共股東將以每股1.43美元的價格出售其持有的每一股Sharecare普通股。Jeff Arnold已同意投票支持該交易，將轉移他現有的幾乎所有股權，並在此次交易後繼續成爲重要股東。此外，Arnold將繼續擔任執行主席，Layton擔任首席執行官，而Sharecare現任高管團隊預計將在交易結束後繼續擔任其職務。所有董事和高管官員合計擁有約30%的優先股。
The transaction agreement unreasonably limits competing transactions for Sharecare by imposing a significant penalty if Sharecare accepts a competing bid. Sharecare insiders will receive substantial benefits as part of change of control arrangements.
該交易協議通過對Sharecare接受其他競標方案的實施強制性懲罰性條款，不合理地限制了其他有競爭性的交易。Sharecare內部人士將受益於控制權變更安排。
We are investigating the conduct of Sharecare's board of directors, and whether they are fulfilling their fiduciary duties to all shareholders.
我們正在調查Sharecare董事會的行爲，以及他們是否履行了對所有股東的信託責任。
If you own Sharecare common stock and wish to obtain additional information, please contact Guri Ademi either at [email protected] or toll-free: 866-264-3995, or
如果您持有Sharecare普通股並希望獲得更多信息，請通過[email protected]或免費電話聯繫Guri Ademi：866-264-3995或
We specialize in shareholder litigation involving buyouts, mergers, and individual shareholder rights throughout the country. For more information, please feel free to call us. Attorney advertising. Prior results do not guarantee similar outcomes.
我們專門從事全國範圍內有關收購、合併和個人股東權利的股東訴訟。欲了解更多信息，請隨時與我們聯繫。律師廣告。之前的業績不保證類似的結果。
Contacts
聯繫方式
Ademi LLP
Guri Ademi
Toll Free: (866) 264-3995
Fax: (414) 482-8001
Ademi LLP
Guri Ademi
免費電話：(866) 264-3995
傳真：(414) 482-8001
SOURCE Ademi LLP
信息來源：Ademi LLP
譯文內容由第三人軟體翻譯。